Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-045172
Filing Date
2022-08-10
Accepted
2022-08-10 16:00:20
Documents
2
Period of Report
2022-08-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2941
2 POA DOCUMENT poa.txt EX-24 3155
  Complete submission text file 0001209191-22-045172.txt   7524
Mailing Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421 617-503-6500
CURIS INC (Issuer) CIK: 0001108205 (see all company filings)

EIN.: 043505116 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O GENOCEA BIOSCIENCES, INC. 100 ACORN PARK DRIVE 5TH FLOOR CAMBRIDGE MA 02140
Business Address
Duvall Diantha (Reporting) CIK: 0001696784 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-30347 | Film No.: 221151717